Zojwalla Naseem
Chief Medical Officer
Zojwalla Naseem has filed 1 SEC Form 4 filing (8 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Dec 23, 2025.
On the most recent filing, Zojwalla Naseem is listed as Chief Medical Officer at Olema Pharmaceuticals, Inc. Inside the rolling window, Zojwalla Naseem reported no open-market purchases and 3 open-market sales totaling $7.5M in OLMA. The largest disclosed transaction in the window is a sale of 100,000 OLMA shares on Dec 22, 2025, worth $2.8M.
Companies traded
Other insiders at OLMA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$7.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Zojwalla Naseem made?
Zojwalla Naseem has filed 1 SEC Form 4 filing (8 transaction rows) across 1 company since 2025.
Which companies does Zojwalla Naseem trade?
Zojwalla Naseem has filed SEC Form 4 disclosures for 1 company, including OLMA.
When was Zojwalla Naseem's most recent SEC Form 4 filing?
Zojwalla Naseem's most recent SEC Form 4 filing on Tracefour is dated Dec 23, 2025.
What is Zojwalla Naseem's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Zojwalla Naseem is listed as Chief Medical Officer.
What is Zojwalla Naseem's total buy and sell value in the current window?
Inside the rolling retention window, Zojwalla Naseem bought $0 and sold $7.5M based on SEC Form 4 filings.
What was Zojwalla Naseem's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 100,000 OLMA shares on 2025-12-22, worth $2.8M, per SEC Form 4 filings.